Patents by Inventor Robert Duncan Stevenson

Robert Duncan Stevenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide factor
    Publication number: 20040213772
    Abstract: The present invention relates to use of oxidised thymosin &bgr;4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response or septic shock. The present invention also provides pharmaceutical formulations comprising oxidised thymosin &bgr;4 together with a suitable excipient.
    Type: Application
    Filed: January 9, 2003
    Publication date: October 28, 2004
    Inventors: Robert Duncan Stevenson, Anthony John Lawrence, John Young, Darryl John Cecil Pappin
  • Oxidized thymosin &bgr;4
    Patent number: 6602519
    Abstract: The present invention relates to the use of oxidized thymosin &bgr;4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response of septic shock.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: August 5, 2003
    Assignees: The University Court of the University of Glasgow, Imperial Cancer Research Technology
    Inventors: Robert Duncan Stevenson, Anthony John Lawrence, John Young, Darryl John Cecil Pappin